HAPVY (Hapvida Participacoes Investimento) Research & Development: $0 Mil (TTM As of Mar. 2026)


HAPVY Hapvida Participacoes Investimento SA HAPVY
67 GF Score
Price $10.01
GF Value $52.85
! 5 Warning Signs
View Full Analysis

What is Hapvida Participacoes Investimento Research & Development?

Hapvida Participacoes Investimento HAPVY -77.73% 67 Research & Development is $0 Mil as of Mar. 2026. GuruFocus rates HAPVY with a GF Score™ of 67/100 and a GF Value™ of $52.85. The stock has 5 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Hapvida Participacoes Investimento's Research & Development for the three months ended in Mar. 2026 was $0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was $0 Mil.

Hapvida Participacoes Investimento  (OTCPK:HAPVY) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Hapvida Participacoes Investimento Research & Development Related Terms

Hapvida Participacoes Investimento Research & Development Historical Data

* Premium members only.

The historical data trend for Hapvida Participacoes Investimento's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hapvida Participacoes Investimento Research & Development Chart

Hapvida Participacoes Investimento Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Hapvida Participacoes Investimento Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
HAPVY
67GF Score
Hapvida Participacoes Investimento SA HAPVY
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hapvida Participacoes Investimento Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0 Mil mean?
Hapvida Participacoes Investimento (HAPVY) has a Research & Development of $0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Hapvida Participacoes Investimento and its competitors.
Is Hapvida Participacoes Investimento's Research & Development too high?
Hapvida Participacoes Investimento's current Research & Development is $0 Mil. Overall, Hapvida Participacoes Investimento has a GF Score™ of 67/100, reflecting its overall financial health beyond just this single metric.
How does Hapvida Participacoes Investimento's Research & Development compare to AFL and MET?
Hapvida Participacoes Investimento's Research & Development of $0 Mil can be compared against companies in the Insurance industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Insurance company?
A good Research & Development depends on the Insurance industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Hapvida Participacoes Investimento and its competitors. Hapvida Participacoes Investimento's current Research & Development is $0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hapvida Participacoes Investimento stock overvalued right now?
Hapvida Participacoes Investimento (HAPVY) has a current Research & Development of $0 Mil. The stock's GF Value™ is $52.85, compared to a current price of $10.01 — trading 81.1% below its estimated fair value. The current Research & Development is $0 Mil. Hapvida Participacoes Investimento's overall GF Score™ is 67/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Hapvida Participacoes Investimento (HAPVY), the current Research & Development is $0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hapvida Participacoes Investimento (HAPVY) Overvalued in 2026?

Based on GuruFocus' analysis, Hapvida Participacoes Investimento stock appears to be undervalued. The current stock price of $10.01 is trading 81.1% below its estimated GF Value™ of $52.85.

Key valuation signals for HAPVY:

  • Research & Development: $0 Mil
  • GF Value™: $52.85 vs. price of $10.01 (81.1% below fair value)
  • GF Score™: 67/100 with 5 warning signs

No single metric tells the full story. See the HAPVY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Hapvida Participacoes Investimento Business Description

Other Exchanges HAPV3:Brazil
Address No. 406, Avenue Heraclito Graca, Fortaleza, CE, BRA, 60140-061
Hapvida Participacoes Investimento SA is the medical-hospital and dental care company. The company and its subsidiaries are mainly engaged in the sale of health insurance plans and delivering the majority of medical assistance at its own hospitals, clinics, imaging diagnostics and laboratories; and the sale of dental insurance plans for services provided by an accredited network.
67GF Score

Get the complete analysis for HAPVY

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$10.01
Price
$52.85
GF Value